ask="N/A"
ask_size="N/A"
average_daily_volume="1285860"
bid="N/A"
bid_size="N/A"
book_value="0.0730"
change="+0.0028"
change_from_200_day_moving_average="-0.0229"
change_from_50_day_moving_average="0.0126"
change_from_52_week_high="-0.2489"
change_From_52_week_low="0.0486"
change_in_percent="+1.6204%"
close="0.1756"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0570"
ebitda="-16.83M"
eps_estimate_current_year="-0.0700"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1000"
ex_dividend_date="N/A"
float_shares="213764000"
high="0.1810"
high_52_weeks="0.4245"
last_trade_date="2/7/2017"
last_trade_price="0.1756"
last_trade_size="1583"
last_trade_time="4:02pm"
low="0.1728"
low_52_weeks="0.1270"
market_capitalization="41.68M"
moving_average_200_day="0.1985"
moving_average_50_day="0.1630"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.5000"
open="0.1738"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-11.5218%"
percent_change_from_50_day_moving_average="+7.7102%"
percent_change_from_52_week_high="-58.6337%"
percent_change_from_52_week_low="+38.2677%"
previous_close="0.1728"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.3671"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="1.4700"
stock_exchange="ASE"
symbol="RNN"
volume="678576"
weeks_range_52="0.1270 - 0.4245"
